LEND: Contemporary Ototoxicity Among Patients with High-Risk Neuroblastoma: A Report from the Children's Oncology Group Study ANBL1531
Product Description:
Assessment of ototoxicity in children diagnosed with high-risk neuroblastoma treated with cisplatin. Among 87 evaluable patients, 56% experienced SIOP grade 2-4 (better ear) ototoxicity at the end of induction therapy.
Keyword(s):
ototoxicity, neuroblastoma, clinical trial, survivorship
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals submitted
Target Audience:
Professionals, Policymakers, Students
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A